EMRIS Pharma vs Upstream Bio

EMRIS Pharma vs Upstream Bio, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: EMRIS Pharma is on 45/100 and Upstream Bio on 61/100.

EMRIS Pharma logo
EMRIS PharmaDeveloping topical treatments to prevent and treat skin toxicities from cancer therapies.
Try EMRIS Pharma
Upstream Bio logo
Upstream BioClinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.
Try Upstream Bio

Where each one leads

EMRIS Pharma

Leads on none of the measures we hold for both companies.

Upstream Bio

  • our overall score: 61/100 against 45/100
  • agent readiness: 39/100 against 30/100
  • domain rating: 32/100 against 10/100
  • headcount: 75 against 7
  • LinkedIn following: 11,799 against 2,441

At a glance

MeasureEMRIS PharmaUpstream Bio
What it isDeveloping topical treatments to prevent and treat skin toxicities from cancer therapies.Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.
CategoryLife Sciences, Oncology, Biotech, MedTechLife Sciences, Therapeutics, Biotech, Drug Discovery
Sells toBusiness modelB2BB2B
OfferingSoftwareServices
Founded20212021
HeadquartersTel Aviv, IsraelWaltham, United States
StatusActiveActive

Size, funding and growth

MeasureEMRIS PharmaUpstream Bio
Employees775
Headcount growthLast 12 monthsNot published+43.4%
Total fundingNot published$400M
Latest roundNot publishedSeries B
LinkedIn followers2,44111,799

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureEMRIS PharmaUpstream Bio
StartupHub scoreOur 0-100 rating45/10061/100
Traction9/10059/100
Team60/10070/100
Search visibility34/10037/100
Quality58/10065/100
Agent readinessHow well an AI agent can read and act on the siteF (30/100)F (39/100)
Domain ratingLink authority, 0-10010/10032/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureEMRIS PharmaUpstream Bio
HostingSelf ManagedNot detected
CDNNot detectedCloudflare
CMSWordPressWordPress
FrameworksJqueryJquery, Bootstrap
AnalyticsNot detectedGoogle Tag Manager

EMRIS Pharma vs Upstream Bio: common questions

Which is better, EMRIS Pharma or Upstream Bio?

On our 0-100 score Upstream Bio rates higher (61/100 against 45/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.

How do EMRIS Pharma and Upstream Bio compare on the numbers?

Upstream Bio leads on our overall score (61/100 against 45/100), agent readiness (39/100 against 30/100), domain rating (32/100 against 10/100), headcount (75 against 7), LinkedIn following (11,799 against 2,441).

Read the full EMRIS Pharma review and pricing or the Upstream Bio review and pricing. You can also browse other EMRIS Pharma alternatives we track.